Gabelli Funds’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-317,145
Closed -$29.5M 1484
2021
Q4
$29.5M Buy
+317,145
New +$20.9M 0.19% 147

Gabelli Funds's ARNA Position: Q1 2022 in Review

Gabelli Funds sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 317,145 shares — an estimated $29.5M sold.

Gabelli Funds first reported a position in ARNA in Q4 2021 and held it in 1 quarter. The position peaked at $29.5M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • Gabelli Funds reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Gabelli Funds sold 317,145 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $29.5M.
  • Gabelli Funds first reported a position in Arena Pharmaceuticals Inc in Q4 2021 and held it in 1 quarter.
  • Gabelli Funds's Arena Pharmaceuticals Inc position peaked at $29.5M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Gabelli Funds's 13F filing for Q1 2022, filed 13 May 2022.